BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 15514029)

  • 1. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
    Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
    Chen A; Vaughan J; Vale WW
    Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A; Blount A; Vaughan J; Brar B; Vale W
    Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity.
    Chen AM; Perrin MH; Digruccio MR; Vaughan JM; Brar BK; Arias CM; Lewis KA; Rivier JE; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2620-5. PubMed ID: 15701705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.
    Parham KL; Zervou S; Karteris E; Catalano RD; Old RW; Hillhouse EW
    Endocrinology; 2004 Aug; 145(8):3971-83. PubMed ID: 15142984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
    Xiong Y; Xie LY; Abou-Samra AB
    Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
    Lovenberg TW; Liaw CW; Grigoriadis DE; Clevenger W; Chalmers DT; De Souza EB; Oltersdorf T
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):836-40. PubMed ID: 7846062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
    Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the chicken growth hormone-releasing hormone receptor (GHRH-R) mRNA and gene: regulation of anterior pituitary GHRH-R mRNA levels by homologous and heterologous hormones.
    Porter TE; Ellestad LE; Fay A; Stewart JL; Bossis I
    Endocrinology; 2006 May; 147(5):2535-43. PubMed ID: 16469800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells.
    Kageyama K; Hanada K; Nigawara T; Furukawa K; Terui K; Ogura E; Motomura S; Suda T
    Peptides; 2007 May; 28(5):1059-67. PubMed ID: 17346851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells.
    Kageyama K; Akimoto K; Suda T
    J Neuroendocrinol; 2010 Sep; 22(9):971-8. PubMed ID: 20626567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K; Gaudriault GE; Suda T; Vale WW
    Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.
    Perrin M; Donaldson C; Chen R; Blount A; Berggren T; Bilezikjian L; Sawchenko P; Vale W
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2969-73. PubMed ID: 7708757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle.
    Kuperman Y; Issler O; Vaughan J; Bilezikjian L; Vale W; Chen A
    Mol Endocrinol; 2011 Jan; 25(1):157-69. PubMed ID: 21084379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
    Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
    Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor.
    Petersenn S; Rasch AC; Penshorn M; Beil FU; Schulte HM
    Endocrinology; 2001 Jun; 142(6):2649-59. PubMed ID: 11356716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
    Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.